Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00366600 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating HKI-272 Administered to Healthy Subjects
A Phase 1 study, sponsored by Puma Biotechnology.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00366600 is a Phase 1 study that has completed, run by Puma Biotechnology. The registered enrollment target is 56 participants.
The verdict
NCT00366600, a Phase 1 study, has completed, sponsored by Puma Biotechnology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
Safety and tolerability of HKI-272 in healthy subjects; the influence of food intake on the same.
Interventions
- DRUG neratinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00366600
The ClinicalTrials.gov registry entry for NCT00366600 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Puma Biotechnology, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which neratinib is the first listed.
NCT00366600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00366600 about?
NCT00366600 is a clinical study titled "Study Evaluating HKI-272 Administered to Healthy Subjects". Safety and tolerability of HKI-272 in healthy subjects; the influence of food intake on the same.
What is the current status of trial NCT00366600?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2006-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00366600?
The interventions under investigation include: neratinib (DRUG).
Who is sponsoring clinical trial NCT00366600?
This trial is sponsored by Puma Biotechnology, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.